Pharmaron Beijing Co., Ltd. (HKG:3759)

Pharmaron Beijing Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 17, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	47,877	44,531	52,187	86,994	130,599	111,980
Market Cap Growth	32.60%	-14.67%	-40.01%	-33.39%	16.63%	155.06%
Enterprise Value	52,111	48,661	56,628	90,505	129,788	107,963
Last Close Price	18.52	13.92	15.24	34.35	50.58	54.97
PE Ratio	23.90	23.33	29.59	55.98	64.05	80.43
PS Ratio	3.52	3.41	4.11	7.50	14.29	18.37
PB Ratio	3.05	2.94	3.58	7.10	10.33	10.56
P/TBV Ratio	4.35	4.16	5.27	10.90	14.50	13.21
P/FCF Ratio	76.19	78.07	-	-	-	283.35
P/OCF Ratio	16.64	16.24	17.20	35.91	51.70	57.20
EV/Sales Ratio	3.75	3.73	4.46	7.80	14.20	17.71
EV/EBITDA Ratio	16.39	17.71	21.15	35.94	57.09	68.62
EV/EBIT Ratio	25.86	26.60	30.42	48.04	73.04	89.13
EV/FCF Ratio	82.92	85.31	-	-	-	273.19
Debt / Equity Ratio	0.41	0.42	0.73	0.56	0.51	0.12
Debt / EBITDA Ratio	2.05	2.17	3.71	2.59	2.72	0.75
Debt / FCF Ratio	10.17	11.15	-	-	-	3.16
Asset Turnover	0.51	0.49	0.49	0.53	0.49	0.47
Inventory Turnover	7.46	7.60	7.23	7.55	9.92	14.65
Quick Ratio	1.32	1.44	2.58	1.31	2.58	2.57
Current Ratio	1.75	1.80	2.98	1.67	2.90	2.80
Return on Equity (ROE)	12.70%	12.48%	13.14%	12.80%	16.85%	13.68%
Return on Assets (ROA)	4.65%	4.26%	4.50%	5.36%	5.97%	5.84%
Return on Capital (ROIC)	5.46%	4.98%	5.29%	6.40%	7.08%	6.76%
Return on Capital Employed (ROCE)	9.20%	8.70%	7.40%	10.10%	9.40%	10.30%
Earnings Yield	4.18%	4.29%	3.38%	1.79%	1.56%	1.24%
FCF Yield	1.31%	1.28%	-0.24%	-1.05%	-0.03%	0.35%
Dividend Yield	1.18%	1.53%	1.45%	0.66%	0.48%	0.29%
Payout Ratio	28.72%	30.24%	27.78%	29.45%	17.14%	11.55%
Buyback Yield / Dilution	0.37%	0.11%	0.05%	2.40%	-1.97%	-20.06%
Total Shareholder Return	1.55%	1.64%	1.50%	3.06%	-1.49%	-19.77%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.